Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
about
Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and RehabilitationReward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s diseaseDisability Rating Scales in Parkinson's Disease: Critique and Recommendations.Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and TreatmentImpact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease PatientsRivastigmine as a Symptomatic Treatment for Apathy in Parkinson's Dementia Complex: New Aspects for This Riddle.Apathy and Reduced Speed of Processing Underlie Decline in Verbal Fluency following DBS.Apathy in Parkinson's disease: A systematic review and meta-analysis.Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.New clinical trials for nonmotor manifestations of Parkinson's disease.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Apathy: a practical guide for neurologists.New and emerging medical therapies in Parkinson's disease.Emotional manifestations of PD: Neurobiological basis.Neuropsychiatric Issues in Parkinson's Disease.Managing cognition in progressive supranuclear palsy.New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.Non-motor features of Parkinson disease.Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease.Gait, posture and cognition in Parkinson's disease.Lille Apathy Rating Scale and MDS-UPDRS for Screening Apathy in Parkinson's Disease.Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy.Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.Serotonergic loss underlying apathy in Parkinson's disease.Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.Treatment of advanced Parkinson's disease.Psychiatric Manifestation in Patients with Parkinson's Disease
P2860
Q26745654-E5406748-5287-4CC0-8006-CB3D473CDB40Q27303483-CACDB754-35A2-4D8B-87DE-4BE2CC0B6825Q30250276-71F0A918-CF72-4345-90EF-4AFE431495FCQ36330202-CD34FC0A-326E-4218-BD8D-D788A41D185AQ37633170-F5169F37-36BB-478B-B37A-98CBC5AA7357Q37733592-0A297490-FF00-4108-9AEB-15BF7FFD69D4Q37734469-4A7F7AB9-5BE6-4BBE-83B0-44AF43B76857Q38383130-A61E9967-FB06-4343-9316-FEDEE8E93F57Q38556646-6635A531-B28E-46D6-BCC1-68B5C0BBAE74Q38587090-8D7C1F64-C272-40C3-ACA2-96DC79909F81Q38588201-25C90A87-9B2C-491E-8DAC-220D7DBB54A2Q38616633-A2426B37-A2B8-4C15-A8FC-CF4F439D335FQ38718194-0B435066-80C7-426A-8ADB-8800B22ED928Q38797335-55A900A6-028E-4DC8-9246-7BC954551467Q38799051-94EDA3E1-83D2-4D1E-87E7-5C599DDF3475Q39017916-3A4D6F4A-2DFE-4B89-B0B7-B9400D6FC9F1Q39323947-C0D28335-2AF8-4E43-A354-E425C6B3FA51Q39358549-233077EA-BA44-4D42-B823-6CF5E37BE880Q40626246-DAC1AD71-232A-435A-8332-E1469235E74AQ47142760-D11FC4FC-3F58-4D68-BC8A-4B80741ACF67Q47449360-68FD44ED-3224-459D-B0CC-313F96271F2AQ47758162-C3C0FEFB-DBFB-4831-B50C-EF05756C657AQ47793861-247F859D-034B-400A-9BF1-91F9990FBCC7Q48553538-66555093-4337-465B-8D91-721FDDCDAB06Q52691511-2EFD89C1-0C9B-4202-A627-A158F88F47CDQ55645561-AA6404E7-4AB8-498B-95A8-225A65522B91Q59131829-C49552D4-AD2E-4BF1-8500-DA2CE1C59EA6
P2860
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@en
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@nl
type
label
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@en
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@nl
prefLabel
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@en
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@nl
P2093
P2860
P50
P921
P356
P1476
Rivastigmine in apathetic but ...... ed, randomised clinical trial.
@en
P2093
Alain Destée
Alain Duhamel
Alexandre Eusebio
Alexandre Kreisler
Caroline Moreau
David Maltête
Gilles Defer
Kathy Dujardin
Marie Delliaux
Pierre Krystkowiak
P2860
P304
P356
10.1136/JNNP-2013-306439
P407
P577
2013-11-11T00:00:00Z